Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 77 | 84 | 80 | 109 | 105 | 114 | 111 | 84 | 92 | 92 | 98 | |
| COGS | 38 | 33 | 39 | 35 | 55 | 50 | 56 | 53 | 42 | 46 | 43 | 46 |
| Gross profit | 41 | 44 | 45 | 45 | 54 | 56 | 58 | 58 | 42 | 46 | 49 | 52 |
| 28 | 28 | 30 | 28 | 36 | 34 | 39 | 34 | 35 | 39 | 37 | 39 | |
| 13 | 16 | 15 | 16 | 18 | 21 | 19 | 24 | 7 | 7 | 12 | 13 | |
| OPM % | 16.8% | 20.6% | 17.9% | 20.5% | 16.5% | 20.2% | 16.5% | 21.6% | 7.9% | 7.8% | 13.3% | 13.4% |
| Depreciation | 2 | 2 | 3 | 2 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 4 |
| Interest | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 2 |
| 1 | 2 | 7 | 2 | 15 | 2 | 2 | -117 | 7 | -0 | 0 | 0 | |
| Profit before tax | 11 | 14 | 17 | 13 | 28 | 16 | 14 | -99 | 8 | 1 | 6 | 8 |
| Tax | 2 | 3 | 5 | 3 | 7 | 6 | 7 | -0 | -4 | -2 | 1 | 1 |
| Tax % | 22.1% | 21.7% | 31% | 27% | 23.5% | 39.2% | 49.2% | -0.1% | -47.6% | -190.1% | 13.4% | 16.6% |
| 8 | 11 | 12 | 9 | 22 | 10 | 7 | -99 | 12 | 3 | 5 | 7 | |
| PAT margin % | 10.6% | 14% | 14% | 11.6% | 19.9% | 9.2% | 6.2% | -89.3% | 14% | 3.2% | 5.3% | 6.6% |
| EPS (₹) | 2.7 | 0.4 | 0.4 | 0.3 | 0.7 | 0.3 | 0.2 | -2.6 | 0.3 | 0.1 | 0.1 | 0.2 |
| Results filing | — | — | — | — | — | — | Results filing for Mar 2025 | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | — |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +2.5% | +17.6% | +10% | +3% | +37.8% | +36.8% | +35.7% | +38.5% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Pharmaceuticals | 85.22 | 7.69 | 0 | 0 |
| Operational and Management | 13.06 | 2.29 | 0 | 0 |
₹ crore by quarter
| -23% |
| -12.4% |
| -18.9% |
| -11.4% |
| PAT YoY % | -29.7% | +15.6% | +24.4% | -8.4% | +159.2% | -10.1% | -40.5% | -1,167.2% | -45.9% | -69.7% | -29.7% | — |